000			03011nam a22003735i 4500
999			_c80309 _d80309 _x1
001			80309
003			ES-MaUEC
005			20230202102528.0
007			cr nn 008mamaa
008			140718s2014 xxu| s |||| 0|eng d
020			_a9781493910137
024	7		_a10.1007/978-1-4939-1013-7 _2doi
040			_dES-MaUEC
050		4	_aRC845 _b.C465 2014
245	1	0	_aCholestatic Liver Disease _cedited by Elizabeth J. Carey, Keith D. Lindor.
250			_a2nd ed. 2014.
260			_aNew York, NY _bSpringer International Publishing _bSpringer International Publishing _c2014
300			_a1 recurso en línea (X, 259 p.) _b34 ilustraciones, 20 ilustraciones en color
336			_aTexto (visual) _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
490	0		_aClinical Gastroenterology _x2197-7399
505	0		_a1. Diagnosis of Cholestasis -- 2. Drug Induced Cholestasis -- 3. Primary Biliary Cirrhosis -- 4. Primary Sclerosing Cholangitis -- 5. IgG4 Related Cholangitis -- 6. Rare Causes of Cholestasis -- 7. Cholestatic Variants of Viral Disease and Alcohol -- 8. Cholestasis Related to Systemic Disorders -- 9. Complications of Cholestasis -- 10. Cholestasis Post Liver Transplantation -- 11. Cholestasis in the Hospitalized Patient -- 12. Endoscopic Management of Biliary Obstruction.
520			_aSince the publication of the first edition, there have been advances in both the diagnosis and the management of many of the cholestatic liver diseases. Cholestatic Liver Disease, Second Edition thoroughly updates the topics previously addressed, such as primary biliary cirrhosis, primary sclerosing cholangitis, and cholestatic variants of drug hepatotoxicity and viral disease. New treatments, such as the development of the farnesoid X receptor agonists for the treatment of PBC, are highlighted. Current guidelines and areas of uncertainty are also covered. Additionally, new chapters have been added to reflect the changing landscape of cholestatic liver disease. Âèolestatic Liver Disease, Second Edition is a concise yet comprehensive summary of the current status of the field and is of value to clinicians and researchers interested in patients with cholestatic liver disease provide that will help to guide patient management and stimulate investigative efforts.
650		7	_2embne _9169917 _aHígado _xEnfermedades
700	1		_aCarey, Elizabeth J. _eeditor literario _0Local _988361
700	1		_aLindor, Keith D _eeditor literario _988362 _0Local
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-1-4939-1013-7 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
907			_a.b12880620 _b10-10-17 _c11-11-15
942			_2lcc _cLE
945			_aRC845 .C465 2014 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11560447 _z06-04-17
988			_aEBSPRINGER
998			_am _a_alco _a_vill _b11-11-15 _cm _dz _e- _feng _gxxu _h0